Kalathil, S. G., Lugade, A. A., Iyer, R., Miller, A., & Thanavala, Y. (2016). Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib. Oncoimmunology.
Citación estilo ChicagoKalathil, Suresh Gopi, Amit Anand Lugade, Renuka Iyer, Austin Miller, and Yasmin Thanavala. "Endothelial Progenitor Cell Number and ERK Phosphorylation Serve As Predictive and Prognostic Biomarkers in Advanced Hepatocellular Carcinoma Patients Treated With Sorafenib." Oncoimmunology 2016.
Cita MLAKalathil, Suresh Gopi, et al. "Endothelial Progenitor Cell Number and ERK Phosphorylation Serve As Predictive and Prognostic Biomarkers in Advanced Hepatocellular Carcinoma Patients Treated With Sorafenib." Oncoimmunology 2016.